USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Biologics Market in Brazil
Biologics Market in Brazil
Regulations and Patent Expirations Challenge Brazilian Laboratories
RELEASE DATE
02-Mar-2012
02-Mar-2012
REGION
Latin America
Latin America
Deliverable Type
Market Research
Market Research
Research Code: N8FD-01-00-00-00
SKU: HC02185-LA-MR_07840
$3,950.00
In stock
SKU
HC02185-LA-MR_07840
This research service considers the biologics market in Brazil. It covers the market’s move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key market drivers and restraints in addition to breaking down the current and forecasted competitive scenario. The base year of the study is 2010, and the forecast period is 2011 to 2017.
Biologics Market
- Biologics
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
This research service considers the biologics market in Brazil. It covers the markets move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key market drivers and restraints in addition to breaking down the current and forecasted competitive scenario. The base year of the study is 2010, and the forecast period is 2011 to 2017.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | N8FD-01-00-00-00 |
| Is Prebook | No |